     |
| Catalog_no | BDMC0017 |
| Product_name | Dalbavancin |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2660.00/6660.00/9560.00 |
| Specificity | Target: Bacterial. Fields: Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regim |
| Dilution | |
| Purification | >99% |
| Concentration | 靶点：Bacterial;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | Dalbavancin;MDL 63397;A-A-1, Dalbavancin Ao, BI 397, MDL 63397;Dalbavancin(BI 397, MDL 63397) |
| Observed_band | 1816.69 |
| Notes | Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. |
